Trials / Completed
CompletedNCT06369740
Case and Use Scenario Study to Gain Knowledge on the User Needs for a Medical Device for Hemophilia a Monitoring
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 74 (actual)
- Sponsor
- Enzyre B.V. · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
This observational study consists of two parts. In part one, case scenario focus groups with hemophilia A patients and healthcare providers (HCPs) will be held. This parts aims to identify potential use scenarios of a point of care (POC) in vitro medical for patients with hemophilia A. The main questions it aims to answer are: * How is coagulation lab testing for patients with hemophilia A currently organized? * What is the interest and what are desired alternatives of a POC in-vitro diagnostic medical device for patients with hemophilia A? Part two of the study consists of a use scenario study in which patients with hemophilia A and HCPs will evaluate two types of non-functional mock-ups of a POC in vitro medical device. The main goal of this part is to evaluate the usability of the current prototypes of the POC device.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Case scenarios - questionnaire | Participants fill in a questionnaire on the current care of hemophilia A and envisioned use scenarios of a point-of-care diagnostic device for hemophilia A. |
| OTHER | Case scenarios - Focus groups | Participants partake in focus groups on the current care for hemophilia A, the envisioned use scenarios of point-of-care diagnostic device for hemophilia A and desired features of such a diagnostic device. |
| OTHER | Use scenarios - Usability test | Participants are asked to perform basic tasks with the mock-ups with minimal instructions, they will also be given a graphic of the user interface (GUI). |
| OTHER | Use scenarios - interview | The participants will be interviewed and asked for their opinions and experiences with the mock-ups. |
Timeline
- Start date
- 2024-08-22
- Primary completion
- 2024-08-25
- Completion
- 2024-08-25
- First posted
- 2024-04-17
- Last updated
- 2024-10-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06369740. Inclusion in this directory is not an endorsement.